BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay

Vaccine

Volumn 27, Issue 44, 2009, Pages 6116-6120

  Eisenhut, Michael ^a   Paranjothy, Shantini ^b   Abubakar, Ibrahim ^e,f   Bracebridge, Sam ^d   Lilley, Mike ^c   Mulla, Rohinton ^a   Lack, Kay ^c   Chalkley, Denise ^g   McEvoy, Marian ^c  

^a BEDFORD HOSPITAL NHS TRUST   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c Bedfordshire and Hertfordshire Health Protection Unit   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e National Infections Surveillance Centre   (United Kingdom)

^f UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^g Liverpool Chest Clinic   (United Kingdom)

Author keywords

BCG immunisation; Gamma interferon release assay; M. tuberculosis infection; Pulmonary tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ARTICLE; BCG VACCINATION; CHILD; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; ETHNICITY; EX VIVO STUDY; HUMAN; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RISK REDUCTION;

BCG VACCINE; CHILD; DISEASE OUTBREAKS; HUMANS; INTERFERON-GAMMA; MALE; MYCOBACTERIUM TUBERCULOSIS; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 70349784995     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.08.031     Document Type: Article

References (14)

1. Trunz B.B., Fine P.E.M., and Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367 (2006) 1173-1180
2. Ewer K., Deeks J., Alvarez L., Bryant G., Waller S., Andersen P., et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361 (2003) 1168-1173
3. Soysal A., Millington K.E., Bakir M., Dosanjh D., Aslan Y., Efe S., et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 366 (2005) 1443-1451
4. Pulickal A.S., and Fernandez G.V.J. Comparison of the prevalence of tuberculosis infection in BCG vaccinated versus non-vaccinated school age children. Indian Pediatr 44 (2007) 344-347
5. International Union against Tuberculosis Lung Disease. Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries with a low prevalence of tuberculosis. A statement of the International Union against Tuberculosis and Lung Disease. Tuberc Lung Dis 75 3 (2004) 179-180
6. Paranjothy S., Eisenhut M., Lilley M., Bracebridge S., Abubakar I., Mulla R., et al. Extensive transmission of Mycobacterium tuberculosis from 9 year old child with pulmonary tuberculosis and negative sputum smear. BMJ 337 August (2008) a1184 10.1136/bmj.a1184
7. Ferrara G., Losi M., D'Amico R., Roversi P., Piro R., Meacci M., et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367 (2006) 1328-1334
8. Pai M., Zwerling A., and Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149 (2008) 177-184
9. Zhang J., and Yu K.F. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280 19 (1998) 1690-1691
10. Cobelens F.G.J., and Verver S. BCG and protection against Mycobacterium tuberculosis infection. Lancet 367 (2006) 392-393
11. Sterne J.A., Rodrigues L.C., and Guedes I.N. Does the efficacy of BCG decline with time since vaccination?. Int J Tuberc Lung Dis 2 (1998) 200-207
12. Bothamley G.H. BCG and protection against Mycobacterium tuberculosis infection. Lancet 367 (2006) 393
13. Garly M.-L., Bale C., Martins C.L., Balde M.A., Hedegaard K.L., Whittle H.C., et al. BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens. Vaccine 20 (2002) 468-474
14. Lienhardt C., and Zumla A. BCG: the story continues. Lancet 366 (2005) 1414-1415